Sangani Hospitals Ltd (SANGANI) — shareholding pattern, promoter holding, financials and share price

About Sangani Hospitals Ltd (SANGANI)

Sangani Hospitals Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as SANGANI and on the BSE under scrip code 79231. Its ISIN is INE0OVI01010.

Incorporated in 2021, Sangani Hospitals is in the business of Hospital, Laboratory, and Pharmacy [1]

Sangani Hospitals Limited is a multi-specialty healthcare provider operating in Keshod and Veraval, Gujarat, with a combined capacity of 68 beds. It offers specialty and super specialty services, pathology labs, and pharmacy stores.

The company recently completed an Initial Public Offering, issuing 3,792,000 equity shares and raising Rs 15 Cr, signifying its intent to expand its financial base.

Listed peers in Hospital: Fortis Malar Hospitals Ltd, Maitreya Medicare Ltd, Shanmuga Hospital Ltd, Aatmaj Healthcare Ltd, Soni Medicare Ltd, KK Shah Hospitals Ltd.

Valuation & Returns

At ₹44.9 a share, Sangani Hospitals Ltd (SANGANI) was valued at a price-to-earnings ratio of 23.36x and a price-to-book of 2.81x on a book value of ₹18.32 per share. Solomo computes return on equity of 12.05% and return on capital employed of 13.76% from filed results.

P/E
23.36x
P/B
2.81x
EPS (TTM)
₹2.22
Book value / share
₹18.32
ROE
12.05%
ROCE
13.76%
ROA
10.98%
Debt / equity
0x
Dividend yield
0%
52-week range
₹40.75 – ₹76

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Sangani Hospitals Ltd (SANGANI) reported revenue of ₹107 crore, net profit of ₹4 crore and earnings per share of ₹2.17. That compares with revenue of ₹21 crore and net profit of ₹3 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹86 crore and net profit ₹3 crore (consolidated).

Consolidated annual results for Sangani Hospitals Ltd (SANGANI), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)4161621107
Net profit (₹ cr)12334
EPS (₹)2.661.531.961.882.17
Compound annual growth for Sangani Hospitals Ltd (SANGANI). Stock price CAGR is price return and excludes dividends.
Measure3Y1Y
Sales growth58.67%35.14%
Profit growth35.53%-4.07%
Stock price CAGR--32%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 74.09% of Sangani Hospitals Ltd (SANGANI) (unchanged from the previous quarter). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2023.

Largest disclosed public shareholders in Jun 2026: JAGGARAJU SATYAVENKATA GURAJAPU 1.48%, CUMULATIVE CAPITAL PRIVATE LIMITED 1%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202674.09%----
Mar 202674.09%----
Sep 202573.22%----
Mar 202573.22%----
Dec 202473.22%----
Sep 202473.22%----
Jun 202473.22%----
Mar 202473.22%----
Every quarter since Sep 2023 Filing data, not investment advice.